Dow Jones Industrial Average ETF vs 10X Genomics Inc — how do they compare? Dow Jones Industrial Average ETF trades at $537.7, while 10X Genomics Inc trades at $57.33 (market cap $7.61B). Which is the better fit depends on your goals.
| DIA | TXG | |
|---|---|---|
52-Week High | $542.79 | $58.57 |
52-Week Low | $444.64 | $11.34 |
Market Cap | — | $7.61B |
Sector | — | Health |
Enterprise Value | — | $7.14B |
Signals from Pluang's Aura AI — not financial advice
DIA trades at $537.63, down 0.25% on the day, with a bullish technical signal driven by moving averages. The stock is near its pivot point of $539, with support at $536 and resistance at $540. Recent dividends include H1-26 payments of $1.41 and $0.28, with another $0.15 scheduled for H2-26.
The outlook is supported by broad market momentum and defensive ETF inflows, though overbought RSI levels suggest near-term caution. Key risks include market volatility and interest rate sensitivity. Analyst sentiment is generally positive given the Dow's performance and institutional interest in blue-chip exposure.
TXG (10x Genomics) trades at $56.95, down 2.77% on the day. The stock exhibits bullish technical signals with strong moving averages, though RSI levels suggest overbought conditions. Fundamentally, the company shows improving trends with Q2 2026 earnings beating estimates and a narrowing net loss margin from -41.23% in 2023 to -12.18% in 2026. Recent news highlights collaborations with Cleveland Clinic and acquisition of Proteintech Genomics, expanding multiomics capabilities.
Outlook: Growth potential exists through market expansion and innovation, but risks include persistent unprofitability and high valuation multiples. Analyst sentiment is mixed with a $46 consensus target below current price, indicating caution despite recent operational improvements.
Trailing returns across standard periods
The ETF is designed to track the performance of the securities and the stocks in the Dow Jones Industrial Average Index. To maintain the composition and weightings, the advisor adjusts the ETF from time to time to conform to periodic changes in the index target.
Read more on DIA →10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →